M A Wallace
Impact in
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders
- Urology top 5%
- Urological Disorders and Treatments
Papers in
-
- Metabolism and Genetic Disorders 2
-
- Neuroscience and Neuropharmacology Research 3
M A Wallace
18 papers receiving 865 citations
Peers
Comparison fields: 5 of 90
- Clinical Biochemistry 131
- Urology 93
- Endocrinology, Diabetes and Metabolism 160
- Molecular Biology 583
- Cellular and Molecular Neuroscience 120
Countries citing papers authored by M A Wallace
This map shows the geographic impact of M A Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M A Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M A Wallace more than expected).
Fields of papers citing papers by M A Wallace
This network shows the impact of papers produced by M A Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M A Wallace. The network helps show where M A Wallace may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M A Wallace, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 3 | |
| 2 | 2001 | 35 | |
| 3 | Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs. | 1997 | 37 |
| 4 | 1997 | 2 | |
| 5 | 1996 | 2 | |
| 6 | 1996 | 3 | |
| 7 | 1993 | 26 | |
| 8 | 1993 | 1 | |
| 9 | 1992 | 3 | |
| 10 | 1992 | 173 | |
| 11 | 1990 | 27 | |
| 12 | 1990 | 15 | |
| 13 | 1989 | 72 | |
| 14 | 1988 | 307 | |
| 15 | 1985 | 10 | |
| 16 | 1985 | 136 | |
| 17 | 1984 | 29 | |
| 18 | 1977 | 25 |
About M A Wallace
M A Wallace is a scholar working on Clinical Biochemistry, Cellular and Molecular Neuroscience, Physiology, Animal Science and Zoology and Infectious Diseases, having authored 18 papers that have together received 906 indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (4 papers), Neuroscience and Neuropharmacology Research (3 papers), HIV/AIDS drug development and treatment (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Metabolism and Genetic Disorders (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Receptor Mechanisms and Signaling (2 papers) and Microbial Natural Products and Biosynthesis (1 paper). The work is most often cited by research in Clinical Biochemistry (131 citations), Urology (93 citations), Endocrinology, Diabetes and Metabolism (160 citations), Molecular Biology (583 citations) and Cellular and Molecular Neuroscience (120 citations). M A Wallace has collaborated with scholars based in United States and France. Frequent co-authors include John N. Fain, Enrique Claro, S. Kling, L F Hofman, I. Lyon, K Fujieda, Horace C. Thuline, Seizo Suwa, C. Dorche and Songya Pang. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Biological Chemistry, The Journal of Urology, Biochemical Journal and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.